Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Isolation Kit
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 30,495 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Novel Combination Therapy for Triple-Negative Breast Cancer based on an Intelligent Hollow Carbon Sphere (2023-04-11)
Journal: Research (2023) IF: 11Products Cited: RPMI-1640 (Glucose free) Medium -
Original research: CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma (2023-12-06)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: Mouse Bone Marrow Mesenchymal Stem cells, GL261 Cells Line -
Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment (2023-11-01)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: Hank's Balanced Salt Solution (HBSS), with calcium, magnesium, without phenol red, Penicillin-Streptomycin Solution, 100 ×, Human Umbilical Vein Endothelial Cells -
PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis (2023-06-01)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: , 4T1 Cells Complete Medium -
MicroRNA-195 liposomes for therapy of Alzheimer's disease (2023-12-06)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: 0.02% EDTA Solution (Versene Solution) -
Inducing in situ M2 macrophage polarization to promote the repair of bone defects via scaffold-mediated sustained delivery of luteolin (2023-12-18)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8 -
Negatively charged bladder acellular matrix loaded with positively charged adipose-derived mesenchymal stem cell-derived small extracellular vesicles for bladder tissue engineering (2023-11-18)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: Human Bone Marrow Mesenchymal Stem Cells Adipogenic Differentiation Medium, Rat Bladder Smooth Muscle Cells, Human Bone Marrow Mesenchymal Stem Cells Osteogenic Differentiation Medium, Human Umbilical Vein Endothelial Cells, Human Bone Marrow Mesenchymal Stem Cells Chondrogenic Differentiation Medium -
Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex (2023-08-12)
Journal: Journal of Advanced Research (2023) IF: 10.7Products Cited: Ham's F-12K, Fetal Bovine Serum -
A spatiotemporal drug release scaffold with antibiosis and bone regeneration for osteomyelitis (2023-01-24)
Journal: Journal of Advanced Research (2023) IF: 10.7Products Cited: Mouse Bone Marrow Mesenchymal Stem cells -
Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway (2023-11-15)
Journal: Clinical and Translational Medicine (2023) IF: 10.6DOI: 10.1002/ctm2.1483Products Cited: MCF 10A Cell Complete Medium
